Company & Sponsor Intelligence
Tanta University
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials3
Recruiting1
Completed2
Countries1
Therapeutic footprint
depressionepilepsypain_neuropathy
Indexed studies
NCT05993871Diabetic Small Fiber Neuropathy: Clinical, Electrophysiological and Neurosonographic Study
pain_neuropathy · EgyptCOMPLETED
pain_neuropathy · EgyptCOMPLETED
NCT07574060Allopurinol in Depression
depression · EgyptPHASE2, PHASE3
depression · EgyptPHASE2, PHASE3
NCT05722951Metformin Efficacy and Safety in Epileptic Patients
epilepsy · EgyptPHASE3
epilepsy · EgyptPHASE3
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →